您当前所在的位置:首页 > 产品中心 > 产品信息
Ajmalicine_分子结构_CAS_483-04-5)
点击图片或这里关闭

Ajmalicine

产品号 Bio-0252 公司名称 InterBioScreen
CAS号 483-04-5 公司网站 http://www.ibscreen.com
分子式 C21H24N2O3 电 话 +7 49652 40091
分子量 352.42686 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 109739

产品价格信息

请登录

产品别名

标题
Ajmalicine
IUPAC标准名
methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
IUPAC传统名
methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate
别名
Lamuran
Py-tetrahydroserpentine
Raubasine
Tetrahydroserpentine
Vinceine
Delta-Yohimbine

产品登记号

CAS号 483-04-5

产品性质

应用领域 Antidiuretic agent
应用领域 Vasodilator
应用领域 CNS depressant
应用领域 Has been used to treat peripheral and cerebral vascular disorders
生物来源 Alkaloid from Alstonia, Amsonia, Cabucala, Catharanthus, Mitragyna, Rauwolfia, Uncaria and Voacanga spp. (Apocynaceae, Naucleaceae)
生物活性机理 Vasodilator
生物活性机理 CYP2D6 inhibitor

产品详细信息

参考文献

  • Klohs, M.W. et al., J.A.C.S., 1954, 76, 1332, (isol, uv, ir)
  • Antonaccio, L.D. et al., J.A.C.S., 1962, 84, 2161, (ms)
  • Shamma, M. et al., J.A.C.S., 1963, 85, 2507, (ir, pmr, config)
  • Laubie, M. et al., Arzneim.-Forsch., 1969, 19, 1820, (pharmacol)
  • van Tamelen, E.E. et al., J.A.C.S., 1969, 91, 7359, (synth)
  • Gutzwiller, J. et al., J.A.C.S., 1971, 93, 5907, (synth, ir, ms, pmr)
  • Levin, R.H. et al., J.O.C., 1973, 38, 1983, (cmr)
  • Lohr, J.P. et al., Arzneim.-Forsch., 1975, 25, 870, (metab)
  • Brown, R.T. et al., Chem. Comm., 1977, 636, (synth)
  • Hernandez, N.M.R. et al., Rev. Cubana Farm., 1977, 11, 249-255, (activity)
  • Stckigt, J., Phytochemistry, 1979, 18, 965, (biosynth)
  • Gutzwiller, J. et al., Helv. Chim. Acta, 1981, 64, 1663, (synth)
  • Wenkert, E. et al., Acta Chem. Scand., Ser. B, 1982, 36, 607, (stereochem, configuration)
  • Seguin, E. et al., Helv. Chim. Acta, 1983, 66, 2059, (cd)
  • Massiot, G. et al., Chem. Comm., 1984, 715, (synth)
  • Lala, P.K., J. Inst. Chem. (India), 1984, 56, 42, (ms)
  • Hatakeyama, S. et al., Tet. Lett., 1985, 26, 865, (synth)
  • Naito, T. et al., Heterocycles, 1986, 24, 2117, (synth)
  • Mekkawi, A.G. et al., Anal. Profiles Drug Subst., 1987, 16, 731, (rev)
  • Morales-Rios, M.S. et al., Magn. Reson. Chem., 1987, 25, 377, (cmr)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 6133
  • Takano, S. et al., Chem. Comm., 1988, 59, (synth)
  • Hirai, Y. et al., J.A.C.S., 1988, 110, 958, (synth)
  • Hanessian, S. et al., J.O.C., 1991, 56, 2947, (synth)
  • Honda, T. et al., J.C.S. Perkin 1, 1993, 539
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 9277
  • Lgers, M. et al., J.A.C.S., 1995, 117, 9139, (synth)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, AFG750